Phenomix Sciences and InformedDNA enter partnership to advance genetics-driven obesity care
top of page
Browse by category
Search
Phenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...
Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership
Phenomix Sciences has entered a partnership with Hello Alpha, a virtual primary care platform, to enable women to take control of their...
MyPhenome Hungry Gut test identifies responders to semaglutide
The results of an independent study led by Mayo Clinic has found that the MyPhenome Hungry Gut test (Phenomix Sciences) can predict a...
Phenomix Sciences launches three-in-one obesity phenotyping test
Phenomix Sciences has launched a new MyPhenome test that now allows patients to test for all three identified phenotypes - Emotional...
Hungry brain test identifies abnormal satiation and predicts response to Qsymia
Results from a study conducted at Mayo Clinic to assess the utility of the Phenomix Sciences MyPhenome Hungry Brain test has demonstrated...
Phenomix Sciences launches MyPhenome Hungry Brain phenotype swab test
Phenomix Sciences has launched its second of its gut-brain axis phenotyping test, MyPhenome Hungry Brain, new buccal swab test that...
Phenomix launches first-of-its-kind test to predict obesity phenotype
Phenomix Sciences (Phenomix) has launched its first therapy selection test, the My Phenome Hungry Gut test is a first-of-its-kind obesity...
Browse by tag
bottom of page